- Jan Aushadhi might make a sale of Rs 600 crore by the end of this fiscal year.
- Jan Aushadhi stores have expanded to 6600 stores from 99 stores in 2014-15
- The sales had witnessed a hike from Rs 7.29 crore in 2014-15 to Rs 433 crore in 2019-20
THD NewsDesk, New Delhi: Union Minister for Chemicals & Fertilizers, Sadananda Gowda, held a meeting to review Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP).
Envisioned to deliver affordable generic medicines, Jan Aushadhi has surpassed its previous fiscal year’s sale of Rs 433 crore. The pharmaceutical products worth Rs 338 crores were marketed through 6600 Jan Aushadhi stores in the first seven months, up till October 31. Jan Aushadhi is expected to outperform Rs 600 crore sales by the end of the entire fiscal year 2020-21.
Appreciating the sales made by PMBJP, Gowda congratulated the BPPI Team for providing an adequate supply of medicines and other pharma products at low costs during the pandemic.
Further, Gowda also suggested measures to bolster the profit by strengthening supply chains through innovative measures.
Directing the BPPI to submit a detailed action plan to implement the same, he highlighted the need to advertise the efficacy and quality of Jan Aushadhi medicines. Aiming to provide affordable pharmaceutical products, BPPI has identified the people from remote and rural areas as their target consumers.
During the meeting, Sachin Kumar Singh, CEO of BPPI, gave a brief presentation elucidating how the PMBJP scheme functions. Moreover, the meeting was attended by the Secretary (Pharmaceuticals) S Aparna and Joint Secretary Rajneesh Tingal.
Source: Express Pharma